CN104223115B - 鱼鳞胶原蛋白多肽的新用途 - Google Patents
鱼鳞胶原蛋白多肽的新用途 Download PDFInfo
- Publication number
- CN104223115B CN104223115B CN201410027581.8A CN201410027581A CN104223115B CN 104223115 B CN104223115 B CN 104223115B CN 201410027581 A CN201410027581 A CN 201410027581A CN 104223115 B CN104223115 B CN 104223115B
- Authority
- CN
- China
- Prior art keywords
- scale collagen
- scale
- polypeptide
- add
- collagen polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108010035532 Collagen Proteins 0.000 title claims abstract description 77
- 102000008186 Collagen Human genes 0.000 title claims abstract description 77
- 229920001436 collagen Polymers 0.000 title claims abstract description 77
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 73
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 72
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 72
- 239000003814 drug Substances 0.000 claims abstract description 15
- 230000000118 anti-neoplastic effect Effects 0.000 claims abstract description 7
- 206010028980 Neoplasm Diseases 0.000 claims description 48
- 238000000034 method Methods 0.000 claims description 20
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 13
- 206010039491 Sarcoma Diseases 0.000 claims description 13
- 238000011282 treatment Methods 0.000 claims description 13
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims description 11
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 claims description 11
- 229960002591 hydroxyproline Drugs 0.000 claims description 11
- 201000005202 lung cancer Diseases 0.000 claims description 11
- 208000020816 lung neoplasm Diseases 0.000 claims description 11
- 239000002994 raw material Substances 0.000 claims description 11
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 claims description 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 10
- 102000004190 Enzymes Human genes 0.000 claims description 10
- 108090000790 Enzymes Proteins 0.000 claims description 10
- LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 claims description 10
- 108091005804 Peptidases Proteins 0.000 claims description 10
- 239000004365 Protease Substances 0.000 claims description 10
- 101000693530 Staphylococcus aureus Staphylokinase Proteins 0.000 claims description 10
- 239000003513 alkali Substances 0.000 claims description 10
- YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 claims description 10
- 229940088598 enzyme Drugs 0.000 claims description 10
- YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 claims description 10
- 239000012467 final product Substances 0.000 claims description 10
- QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 claims description 10
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 235000019419 proteases Nutrition 0.000 claims description 8
- 241000276701 Oreochromis mossambicus Species 0.000 claims description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 238000010792 warming Methods 0.000 claims description 6
- 108010019160 Pancreatin Proteins 0.000 claims description 5
- 229940055695 pancreatin Drugs 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 4
- 238000005189 flocculation Methods 0.000 claims description 4
- 230000016615 flocculation Effects 0.000 claims description 4
- 239000013049 sediment Substances 0.000 claims description 4
- 102000005158 Subtilisins Human genes 0.000 claims description 3
- 108010056079 Subtilisins Proteins 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 108010007119 flavourzyme Proteins 0.000 claims description 2
- 108010009355 microbial metalloproteinases Proteins 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 10
- 235000013305 food Nutrition 0.000 abstract description 9
- 230000037213 diet Effects 0.000 abstract description 7
- 235000005911 diet Nutrition 0.000 abstract description 7
- 230000036541 health Effects 0.000 abstract description 6
- 230000005909 tumor killing Effects 0.000 abstract 1
- 241000251468 Actinopterygii Species 0.000 description 15
- 230000002401 inhibitory effect Effects 0.000 description 11
- 239000000843 powder Substances 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 10
- 239000006228 supernatant Substances 0.000 description 10
- 239000000047 product Substances 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 238000005292 vacuum distillation Methods 0.000 description 7
- 230000037396 body weight Effects 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000003304 gavage Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 206010006187 Breast cancer Diseases 0.000 description 5
- 208000026310 Breast neoplasm Diseases 0.000 description 5
- 230000000259 anti-tumor effect Effects 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 230000004614 tumor growth Effects 0.000 description 5
- 201000009365 Thymic carcinoma Diseases 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 235000013402 health food Nutrition 0.000 description 4
- 238000011081 inoculation Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 208000008732 thymoma Diseases 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 238000012449 Kunming mouse Methods 0.000 description 3
- 241000699660 Mus musculus Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000011580 nude mouse model Methods 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 241000252230 Ctenopharyngodon idella Species 0.000 description 2
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 2
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 2
- 208000007433 Lymphatic Metastasis Diseases 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000008394 flocculating agent Substances 0.000 description 2
- 210000003194 forelimb Anatomy 0.000 description 2
- 239000000413 hydrolysate Substances 0.000 description 2
- 230000000937 inactivator Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000012109 statistical procedure Methods 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 238000011729 BALB/c nude mouse Methods 0.000 description 1
- 206010048612 Hydrothorax Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 206010027458 Metastases to lung Diseases 0.000 description 1
- 101710180313 Protease 3 Proteins 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000004833 fish glue Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 238000011532 immunohistochemical staining Methods 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000005296 lung carcinoma Diseases 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 210000004088 microvessel Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 210000004043 pneumocyte Anatomy 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 235000020254 sheep milk Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/04—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from fish or other sea animals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410027581.8A CN104223115B (zh) | 2013-06-17 | 2014-01-21 | 鱼鳞胶原蛋白多肽的新用途 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310238122 | 2013-06-17 | ||
CN201310238122.X | 2013-06-17 | ||
CN201310238122X | 2013-06-17 | ||
CN201410027581.8A CN104223115B (zh) | 2013-06-17 | 2014-01-21 | 鱼鳞胶原蛋白多肽的新用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104223115A CN104223115A (zh) | 2014-12-24 |
CN104223115B true CN104223115B (zh) | 2017-04-05 |
Family
ID=52212722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410027581.8A Active CN104223115B (zh) | 2013-06-17 | 2014-01-21 | 鱼鳞胶原蛋白多肽的新用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104223115B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105341767A (zh) * | 2015-12-09 | 2016-02-24 | 哈尔滨神守生物科技有限公司 | 一种甲鱼蛋白肽的制备方法 |
CN107494838A (zh) * | 2017-08-30 | 2017-12-22 | 兰溪市哥特生物技术有限公司 | 深海鱼鱼鳞制备的蛋白多肽的复配物 |
CN109350731A (zh) * | 2018-12-18 | 2019-02-19 | 汕尾市维明生物科技股份有限公司 | 一种罗非鱼蛋白肽在制备免疫制剂中的应用 |
CN110787287B (zh) * | 2019-12-13 | 2022-09-23 | 海南康恩美生物科技有限公司 | 一种鱼鳞胶原蛋白多肽在制备治疗慢性心力衰竭药物中的应用 |
CN111990652B (zh) * | 2020-09-08 | 2023-05-09 | 湖北省农业科学院农产品加工与核农技术研究所 | 一种灵芝胶原肽粉及其制备方法 |
CN112574293B (zh) * | 2020-12-11 | 2022-12-16 | 浙江万里学院 | 一种利用超声辅助从鳖背甲中脱钙提取胶原蛋白的工艺 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101289507A (zh) * | 2007-04-17 | 2008-10-22 | 史宗洁 | 一种胶原蛋白及胶原多肽及其制备方法和应用 |
CN101787078A (zh) * | 2009-01-23 | 2010-07-28 | 香港百特有限公司 | 一种胶原蛋白多肽及其制备方法和用途 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005318878A (ja) * | 2004-05-07 | 2005-11-17 | Hideyo Sasaya | 健康食品 |
KR100990561B1 (ko) * | 2007-08-16 | 2010-10-29 | 이상문 | 조류 깃털 및 어류 비늘의 혼합물을 유효성분으로 함유하는세포증식성 질병의 예방 및 치료용 약학적 조성물 |
-
2014
- 2014-01-21 CN CN201410027581.8A patent/CN104223115B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101289507A (zh) * | 2007-04-17 | 2008-10-22 | 史宗洁 | 一种胶原蛋白及胶原多肽及其制备方法和应用 |
CN101787078A (zh) * | 2009-01-23 | 2010-07-28 | 香港百特有限公司 | 一种胶原蛋白多肽及其制备方法和用途 |
Also Published As
Publication number | Publication date |
---|---|
CN104223115A (zh) | 2014-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104223115B (zh) | 鱼鳞胶原蛋白多肽的新用途 | |
Cao et al. | Antitumor activity of polysaccharide extracted from Pleurotus ostreatus mycelia against gastric cancer in vitro and in vivo | |
CN105586379B (zh) | 一种具有抑制癌细胞增殖作用的胶原蛋白活性肽的制备方法 | |
CN108753874A (zh) | 一种小分子活性肽新型螺旋藻粉的制备方法 | |
CN104758977B (zh) | 一种治疗褥疮的海藻酸盐敷料及其制备方法 | |
CN101787078B (zh) | 一种胶原蛋白多肽及其制备方法和用途 | |
CN102851344B (zh) | 一种螺旋藻抗肿瘤多肽的制备方法 | |
CN103275181B (zh) | 一种金枪鱼碎肉多肽类血管生成抑制因子及其制备方法和用途 | |
CN107550900A (zh) | 冬凌草甲素在制备蛋白激酶b抑制剂方面的应用 | |
CN106075384A (zh) | 豌豆活性肽在抑制癌细胞生长中的应用及其制备方法 | |
CN106834404A (zh) | 一种酶解多肽及用于制备治疗肺腺癌药物的用途 | |
CN105670998B (zh) | 一种钙化癌细胞的方法 | |
CN1895244A (zh) | 一种预防及治疗癌症的药物组合物 | |
CN1824775A (zh) | 重组人血管抑素k1-3的制备工艺及其制品在肿瘤治疗药物中的应用 | |
CN112641924B (zh) | 一种治疗甲状腺癌的药物及其制备方法和用途 | |
CN100544736C (zh) | 一种增强免疫力的药物组合物及制备方法 | |
CN104232714A (zh) | 龟甲胶多肽的制备方法和制药新用途 | |
CN113875989A (zh) | 一种功能化水溶性纳米硒、制备方法及应用 | |
CN102503892A (zh) | 含钴夹心杂多酸及其合成方法和应用 | |
CN102389412B (zh) | 一种治疗白内障的滴眼液 | |
CN112245452A (zh) | 一种骨提取物的制备方法及对骨质疏松和骨关节炎的应用 | |
CN104223056B (zh) | 龟甲胶在制备治疗肿瘤的药物中的用途 | |
WO2021004053A1 (zh) | 通过原癌基因蛋白共振抑制乳腺癌细胞生长的胸罩 | |
CN100475227C (zh) | 一种抗肿瘤的药物组合物及其制备方法 | |
CN1179749C (zh) | 肿瘤特异性转移因子的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210903 Address after: 430000 No. 4, 6 / F, No. 19-4, Chezhan Road, Jiang'an District, Wuhan City, Hubei Province Patentee after: Wei Shan Patentee after: Zhang Rongcun Address before: 430079 No. 3, door 4, building 13, No. 116, Zhuodaoquan South Road, Hongshan District, Wuhan City, Hubei Province Patentee before: Shi Zongjie Patentee before: Wei Shan Patentee before: Zhang Rongcun |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211207 Address after: 570100 room a26-160, floor 5, business incubation center, No. 266, Nanhai Avenue, national high tech Industrial Development Zone, Haikou City, Hainan Province Patentee after: Hainan kangenmei Biotechnology Co.,Ltd. Address before: 430000 No. 4, 6 / F, No. 19-4, Chezhan Road, Jiang'an District, Wuhan City, Hubei Province Patentee before: Wei Shan Patentee before: Zhang rongcun |
|
TR01 | Transfer of patent right |